MDN-001 Injection

· Suzhou Mednovo Yi Medical Technology Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for MDN-001 Injection, covering 2026-02-06 to 2026-02-06. Get the full timeline:

Most recent: Clinical Trial Update: MDN-001 Injection for the Treatment of Unresectable Primary Hepatocellular Carcinoma. [Phase 1]